Ginsenosides-induced bone marrow mesenchymal stem cells promote nerve regeneration in traumatic brain injury
10.3969/j.issn.2095-4344.2015.45.014
- VernacularTitle:人参皂苷诱导骨髓间充质干细胞促进创伤性颅脑损伤的神经再生
- Author:
Jun QIN
;
Jiakang CHEN
;
Xuedong LI
;
Yongjun MAI
;
Zhenyong XIAO
- Publication Type:Journal Article
- Keywords:
Craniocerebral Trauma;
Ginsenosides;
Bone Marrow;
Mesenchymal Stem Cel Transplantation;
Tissue Engineering
- From:
Chinese Journal of Tissue Engineering Research
2015;(45):7292-7297
- CountryChina
- Language:Chinese
-
Abstract:
BACKGROUND:Previous studies have shown that bone marrow mesenchymal stem cels in the treatment of neurological diseases have achieved some success, which can promote neurological alterations; however, there is no breakthrough on gene and drug regulation. OBJECTIVE:To investigate the influence of ginsenosides-induced differentiation of bone marrow mesenchymal stem cels on nerve regeneration after traumatic brain injury. METHODS: A traumatic brain injury model was built in rats using hydraulic shock method, and then rat models were randomly divided into model group (traumatic brain injury group), bone marrow mesenchymal stem cel group, ginsenosides group (ginsenosides induced differentiation of bone marrow mesenchymal stem cels). At 2 weeks after transplantation, western blot assay was used to detect protein expression levels of nerve growth factor and brain-derived neurotrophic factor, immunohistochemistry assay used to detect the number of BrdU-positive cels. At 1, 3 days and 1, 2 weeks after transplantation, modified neurological severity scores were recorded. RESULTS AND CONCLUSION: The expression levels of nerve growth factor and brain-derived neurotrophic factor protein were significantly higher in the ginsenosides group than the bone marrow mesenchymal stem cel group and model group (P < 0.05). The number of BrdU positive nerve cels was also higher in the ginsenosides group than the bone marrow mesenchymal stem cel group and model group (P < 0.05). At 3 days and 1, 2 weeks after transplantation, the modified neurological severity scores in the ginsenosides group were lower than those in the bone marrow mesenchymal stem cel group and model group (P< 0.05). These findings indicate that ginsenoside-induced bone marrow mesenchymal stem cel transplantation can promote nerve regeneration in rats with traumatic brain injury, which has better outcomes than bone marrow mesenchymal stem cel transplantation alone.
